"10.1371_journal.pone.0077587","plos one","2013-10-16T00:00:00Z","Hilda JI De Jong; Jan GMC Damoiseaux; Rob J Vandebriel; Patrick C Souverein; Eric R Gremmer; Mia Wolfs; Olaf H Klungel; Henk Van Loveren; Jan Willem Cohen Tervaert; WM Monique Verschuren","Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University Medical Centre, Maastricht, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Central Diagnostic Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands; Immunology, Maastricht University Medical Centre, Maastricht, The Netherlands; Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands","Conceived and designed the experiments: HJIDJ JGMCD RJV PCS OHK HVL JWCT WMMMV. Performed the experiments: HJIDJ EG MW. Analyzed the data: HJIDJ. Contributed reagents/materials/analysis tools: JGMCD RJV PCS OHK HVL JWCT WMMV. Wrote the manuscript: HJIDJ. Contributed to the interpretation of the results: HJIDJ JGMCD OHK JWCT WMMV
Provided the background data for the study: JGMCD RJV PCS OHK HVL JWCT WMMV
Reviewed and approved the manuscript: JGMCD RJV PCS EG MW OHK HVL JWCT WMMV.","I have read the journals policy and have the following conflicts: Dr. P.C. Souverein has received unrestricted funding for pharmacoepidemiological research from the private-public EU funded IMI (PROTECT project). Dr. O.H. Klungel has received unrestricted funding for pharmacoepidemiological research from the private-public EU funded IMI (PROTECT project) and the private-public Dutch Top Institute Pharma (Mondriaan project).","2013","10","Hilda JI De Jong","HJIDJ",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
